← FDA Drug Approvals (Drugs@FDA)

SAXENDA

NDA · New Drug Application · Sponsor: NOVO · Approved 2014-12-23

Drug application

FDA Application #

NDA206321

Application type

New Drug Application

Brand name

SAXENDA

Generic name

LIRAGLUTIDE

Active ingredients

LIRAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

NOVO

Manufacturer

Novo Nordisk

First approval

2014-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown